Total Live Articles: 401

Cutaneous Warts

NICE CKS Warts and verrucae. Last revised: Oct 2024.

Cutaneous Warts

Cutaneous warts are benign skin lesions caused by human papillomavirus (HPV) infection of keratinocytes on keratinised skin.

This updated UKMLA guide is based on NICE CKS, which covers common warts, plane / flat warts, plantar warts and filiform warts, including causes, recognition, diagnosis and management.

Causes and Risk Factors

Most cases are caused by HPV types 1, 2, 4, 27 or 57, and plane warts by HPV types 3 or 10. [Ref]

The key takeaway is that high-risk HPV strains (e.g. 16, 18, 31, and 33) do NOT  cause cutaneous warts.

Instead, they are primarily associated with cervical cancer and other HPV-related malignancies (e.g. anal cancer, vulval cancer, penile cancer).

Warts are usually spread by direct skin-to-skin contact or indirectly via contact with contaminated floors or surfaces.

Risk factors:

  • Skin breaks / damage / microtrauma
  • Scratching / picking/ knocking on an existing wart (e.g. warts on fingers may spread widely around the nails in those who bite their nails)
  • Occupation involves regular direct handling of meat or fish (higher risk of hand warts)
  • Frequent water immersion (e.g. swimming, regular dishwashing)
  • Immunocompromised

Clinical Features and Diagnosis

Cutaneous warts are primarily a clinical diagnosis

  • Further investigations are not required
  • Dermoscopy examination may be helpful if there is diagnostic uncertainty
Wart type Appearance
Common wart (verruca vulgaris) The classic cauliflower-like lesion

  • Raised, outward-growing lesion (exophytic papules)
  • Firm, rough surface, hyperkeratotic
  • Rough, irregular “cauliflower-like” surface
  • Skin-coloured or grey-brown
  • Common on knuckles, fingers (periungual warts), and the knees

Usually asymptomatic

Flat warts or plane warts (verrucae planae)
  • Small, round, flat-topped papules
  • Smooth surface (less hyperkeratotic than common warts)
  • Skin-coloured or grey-yellow lesions
  • Common on the face, back of hands, and shins

Usually asymptomatic

Plantar warts (verrucae plantares)
  • Hyperkeratotic papules found on the sole of the foot
  • Black dots may be visible (thrombosed capillaries)
  • Plantar warts can coalesce into larger plaques (called mosaic warts)

May be painful (e.g. on walking)

Filiform warts
  • Thin, elongated, finger-like projections
  • Often pedunculated / stalk-like
  • More common on the face (e.g. around the eyelid and lips) and neck

Usually asymptomatic

Malignant transformation of cutaneous warts is rare, but has been reported in immunosuppressed patients.

Lesions may initially have appeared as warts and later transform into squamous cell carcinoma.

Anogenital warts (condylomata acuminata) are considered a separate category from cutaneous warts, as it does NOT occur on keratinised skin.

Management

Referral to dermatology should be considered if ANY of the following:

  • Facial wart
  • Immunocompromised
  • Extensive skin involvement (e.g. mosaic warts)
  • Refractory to primary care treatment options

General / Conservative Management

Patient education Advise that:

  • Warts are NOT harmful
  • They tend to resolve spontaneously
Measures to reduce risk of transmission Warts are contagious, but the risk of transmission is thought to be low

To reduce the risk of spread to other individuals:

  • Cover the wart with a waterproof plaster when swimming
  • Avoid going barefoot in public places (e.g. wear flip-flops)
  • Avoid sharing shoes / socks / towels

To reduce the risk of auto-inoculation:

  • Avoid picking / scratching lesions
  • Avoid nail biting and finger sucking
  • Keep feet dry and change socks / tights daily
Activity exclusion Children with warts or verrucae should not be excluded from activities (e.g. sports, swimming)

But should take care to minimise transmission

Indications to Treat

Most cases do NOT require treatment, rationale:

  • Most cases are asymptomatic and resolve spontaneously
  • This is especially true in children, as warts are more likely to resolve spontaneously, and treatment could be uncomfortable or not tolerated
  • Treatment is relatively lengthy and has adverse effects

Consider treatment if ANY of the following:

  • Painful wart (e.g. plantar warts and periungual warts)
  • Cosmetically unsightly (e.g. on the face and hands)
  • Patient requests treatment in cases of persistent warts

Cryotherapy requires several treatments, can be painful at the time of application, and may cause pain, blistering, infection, scarring, and depigmentation.

Topical salicylic acid may require administration for up to 12 weeks and can cause local skin irritation.

Treatment Options

Primary care treatment options (the exact choice depends on what has been tried already and what the patient prefers):

Treatment option Description / notes
Topical salicylic acid To be applied for up to 12 weeks

Preferred in younger children

Cryotherapy (with liquid nitrogen) Usually carried every 2-4 weeks until the wart is resolved (up to a maximum of 6 treatments)

Cryotherapy should NOT be used in young children.

Combination therapy Topical salicylic acid being applied between cryotherapy sessions

More likely to be helpful in plantar warts (cryotherapy alone is less likely to resolve it, and more aggressive cryotherapy might be necessary)

Secondary care options:

  • Physical ablation (e.g. surgery, laser, microwave, photodynamic treatment)
  • Antimitotic treatments (e.g. topical podophyllin, retinoids, intralesional bleomycin)
  • Immunomodulatory treatments
  • Topical 5-fluorouracil

References

Related Articles

Anogenital Warts

Share Your Feedback Below

Disclaimer

We’re actively expanding Guideline Genius to cover the full UKMLA content map. Therefore, you may notice some conditions not uploaded yet, or articles that currently focus on diagnosis and management for now.

We are also continuously reviewing and updating existing content to ensure accuracy and alignment with current guidelines. Some earlier articles are undergoing revision as part of this process. Once all content has been fully reviewed, this will be clearly communicated on the platform.

For updates, follow us on Instagram @guidelinegenius.

We welcome any feedback or suggestions via the anonymous feedback box at the bottom of each article and will do our best to respond promptly.

Thank you for your support.
The Guideline Genius Team

UK medical guidelines made easy. From guidelines to genius in minutes!

Quick Links

Cookie Policy

Social Media

© 2026 GUIDELINE GENIUS LTD

Stay Updated withGuideline Genius

Sign up to be notified when our newsletter launches, covering major guideline updates, article updates, and future UKMLA resources.